Neuralink has enrolled 21 participants worldwide in its human brain-chip trials, up from 12 in 2024. Elon Musk said the Telepathy implant enables users with paralysis to control devices using thoughts. The trials focus on spinal injuries and ALS, with zero serious adverse events reported so far.